Screener
MEI Pharma LITS Q4 2024 earnings
Reported December 31, 2024
EPS-$0.40Beat by $1.80
EPS estimate-$2.20
Next report
Sep 28, 2026 (in a month)Revenue estimate$5.4M
EPS estimate-$3.12
Versus estimates
Diluted EPS
Q1 2026-$0.66Beat by $2.46Q4 2025-$0.82Q3 2025-$0.12Q2 2025-$0.40Q1 2025-$0.39
Q4 2024-$0.40Beat by $1.80
FAQ
- When did MEI Pharma report Q4 2024 earnings?
- MEI Pharma (LITS) reported Q4 2024 earnings on December 31, 2024.
- What were MEI Pharma's Q4 2024 revenue and EPS?
- MEI Pharma reported eps of $-0.40 for Q4 2024.
- Did MEI Pharma beat estimates in Q4 2024?
- EPS beat the consensus estimate of $-2.20 by $1.80.
- Where can I find MEI Pharma's Q4 2024 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-018809) directly on SEC EDGAR. The filing index links above go to sec.gov.
